Financial Performance - For the six months ended September 30, 2025, the group's revenue was approximately HKD 160.08 million, a decrease of about HKD 40 million or 20.0% compared to HKD 200.08 million for the same period in 2024[3] - The loss attributable to the company's owners for the six months ended September 30, 2025, was approximately HKD 0.3 million, compared to a loss of HKD 0.6 million for the same period in 2024[3] - Total revenue for the six months ended September 30, 2025, was HKD 160,080,000, a decrease of approximately HKD 40,000,000 or 20.0% compared to HKD 200,076,000 for the same period in 2024[28] - The group recorded a loss of HKD 335,000 for the six months ended September 30, 2025, compared to a loss of HKD 630,000 for the same period in 2024[20] - The company's basic and diluted loss per share for the six months ended September 30, 2025, was HKD 0.08, compared to HKD 0.16 for the same period in 2024[4] Assets and Liabilities - Total non-current assets as of September 30, 2025, amounted to HKD 132.07 million, down from HKD 156.29 million as of March 31, 2025[5] - Current assets totaled HKD 322.59 million as of September 30, 2025, compared to HKD 314.99 million as of March 31, 2025[5] - The total liabilities for current liabilities were HKD 262.67 million as of September 30, 2025, slightly down from HKD 263.85 million as of March 31, 2025[6] - The total equity as of September 30, 2025, was HKD 147.37 million, slightly down from HKD 147.56 million as of March 31, 2025[6] - Trade receivables at the end of the reporting period were HKD 2,695,000, down from HKD 3,888,000 as of March 31, 2025[22] - Trade payables at the end of the reporting period totaled HKD 9,376,000, an increase from HKD 6,336,000 as of March 31, 2025[24] Revenue Breakdown - Revenue from external customers in Hong Kong was HKD 158.85 million for the six months ended September 30, 2025, compared to HKD 195.04 million for the same period in 2024[12] - Revenue from external customers in Mainland China was HKD 1.23 million for the six months ended September 30, 2025, down from HKD 5.04 million for the same period in 2024[12] - Revenue from medical consultation services remained stable at HKD 2,000 for both periods, while revenue from skincare products decreased from HKD 29,336,000 to HKD 18,477,000[15] Expenses and Cost Management - Employee costs decreased by approximately HKD 12.1 million or 16.3% to about HKD 62.1 million during the review period, primarily due to operational efficiency improvements[30] - Property rental and related expenses reduced by approximately HKD 4.1 million or 14.2% to about HKD 24.8 million, mainly due to optimized sales network and better lease terms[31] - Other net expenses decreased by approximately HKD 12.4 million or 24.1% to about HKD 39 million, attributed to enhanced operational efficiency and effective cost control[33] - The cost of inventory and consumables for the current and prior periods was approximately HKD 22,110,000 and HKD 25,400,000, representing 13.8% and 12.7% of total revenue, respectively[29] - Depreciation of property, plant, and equipment was HKD 13,873,000 for the six months ended September 30, 2025, down from HKD 19,259,000 in 2024[16] Dividends and Shareholder Returns - The board did not declare an interim dividend for the six months ended September 30, 2025, consistent with the previous period[3] - The group did not declare any interim dividends for the six months ended September 30, 2025, consistent with the previous year[19] Strategic Outlook - The group plans to continue enhancing operational efficiency and resource allocation to maintain stability and growth amid economic uncertainties[25] - The group aims to leverage its brand strength and service quality to provide better customer experiences and greater value for stakeholders in the upcoming period[27] - The company plans to adopt a cautious and prudent operational strategy in response to structural changes in the consumer market[49] Financial Health - As of September 30, 2025, the company maintained a healthy financial position with cash and cash equivalents of approximately HKD 186.6 million[38] - The debt-to-equity ratio as of September 30, 2025, was approximately 1.7%, down from 4.0% as of March 31, 2025[43] - The company has no significant contingent liabilities or guarantees as of September 30, 2025[41] - The company has not made any significant investments or acquisitions during the review period[46] Corporate Governance - The audit committee has been established in accordance with the listing rules and corporate governance code, consisting of three independent non-executive directors[54] - The audit committee is chaired by Mr. Zheng Yuhua, who has suitable accounting and financial management expertise[54] - The financial information for the review period has not been reviewed by the independent auditor but has been reviewed by the audit committee[54] - The board of directors includes three executive directors and three independent non-executive directors as of the announcement date[55] Workforce - The company employed a total of 255 employees as of September 30, 2025, compared to 242 employees in the previous year[47]
卓珈控股(01827) - 2026 - 中期业绩